Biological and glucocorticoids treatment impair the medium-term immunogenicity to SARS-CoV-2 mRNA vaccines in autoimmune inflammatory rheumatic diseases

Biological and glucocorticoids treatment impair the medium-term immunogenicity to SARS-CoV-2 mRNA vaccines in autoimmune inflammatory rheumatic diseases

Abstract Background This study aims to assess the sustained immunological response to the SARS-CoV-2 vaccine in patients with autoimmune inflammatory rheumatic diseases (AIRD) undergoing different treatment regimens. Methods We conducted a prospective observational study involving 157 AIRD patients...

Full description

Bibliographic Details
Main Authors: Silvia Garcia-Cirera, Joan Calvet, Juan Francisco Delgado de la Poza, Antoni Berenguer-Llergo, Cristóbal Orellana, Menna Rusiñol, Maria Llop, Marta Arévalo, Alba Garcia-Pinilla, Ester Costa, Cristina Aymerich, Rafael Gómez, Anna Carreras, Jordi Gratacós
Format: Article
Language:English
Published: BMC 2024-01-01
Series:European Journal of Medical Research
Subjects:
Autoimmune disease
Immune response
COVID19
Neutralizing antibodies
Online Access:https://doi.org/10.1186/s40001-023-01620-7

Internet

https://doi.org/10.1186/s40001-023-01620-7

Similar Items